BioSpace News Archive

Freenome, a privately held biotech company, announced three executives have joined the company to support its continued growth.

Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR.

Sonnet BioTherapeutics Holdings, Inc. today announced that the Company’s 2022 Annual Meeting of Stockholders, on June 2, 2022 at 9:00 a.m. Eastern Time, was convened and adjourned, without any business being conducted, due to lack of the required quorum.

Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that its Chief Executive Officer, Mark Emalfarb will present at the 2022 Jefferies Healthcare Conference.

Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $43 million first close of its Series F financing.

The global animal therapeutics and diagnostics market size was reached at US$ 33,462.50 million in 2020, and it is projected to hit US$ 59,082.10 million by 2030, growing at a CAGR of 6% from 2021 to 2030.

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that its virtual Annual Meeting of Stockholders (the “Annual Meeting”) will be held on Thursday, June 16, 2022 at 1:00 p.m. PT.

Net Health, a provider of specialty electronic healthcare record (EHR) and predictive analytics software, announced today that Tissue Analytics, the company’s AI-powered wound imaging and analysis software, has been granted Breakthrough Device Status by the U.S. Food & Drug Administration (FDA).

Sirius Medical is pleased to announce that Ascension St. Vincent Carmel and Ascension St. Vincent Evansville are the first U.S. hospitals to implement the Pintuition System in their breast surgery programs.

ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering transformative cell and gene therapies, today announced that Jill M. Mooney, Ph.D., has joined as Senior Vice President of Research and Development (R&D).